Priority Date: 08.03.12 (EP 20120158519)

COMBINATION THERAPY OF ANTIBODIES AGAINST HUMAN CSF-1R AND USES THEREOF

  • Application ID: EP13708156
  • Status: GRANT OF PATENT INTENDED

Applicant

Technology company logo small
Technology Company

Attorney

no operation time available
2 offices
Technology Company

Specialization

This patent has the IPC combination A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE) and C07 (ORGANIC CHEMISTRY) is specialized in the combination A61 and C07. We found, that TransMIT GmbH, Kailuweit & Uhlemann, Lederer Keller Patentanwälte Partnerschaft mbB, Vossius & Partner Patentanwälte Rechtsanwälte mbB, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB and 190 others are specialized in all of these IPC classes. For a similar patent, they might be a good choice.

Timeline

  • 08.03.2012 - Priority Date (EP 20120158519)
  • 12.09.2013 - Publication A1 (WO2013132044)
  • 14.01.2015 - Publication A1 (EP2822588)